NEW PRODUCTS Kips Bay Medical Inc., Plymouth, said the U.S. Food and Drug Administration has granted approval for additional U.S. patients to be enrolled in Kips Bay Medical's eMESH I clinical feasibility trial of its eSVS Mesh. In its initial approval, the FDA indicated it would allow a staged enrollment within the United States, starting with five patients at up to four sites in the United States. The FDA has now increased the approved number of patients to 15.
NEW BUSINESS Parameters, Minneapolis, an office furniture dealership, is under new ownership. David Haines and Lauri Bolin, vice presidents, purchased controlling interest in the firm from Jack Benedict, who retired as president and chief executive officer on Dec. 31. Haines will become partner and CEO and Bolin will become partner and chief financial officer.
DEBT AND EQUITIES Winmark Corp., Minneapolis, has approved a quarterly cash dividend of 4 cents per share, payable March 1 to shareholders of record Feb. 6.
Allete Inc., Duluth, has increased the quarterly dividend on its common stock to 47.5 cents per share, payable March 1 to common shareholders of record Feb. 15.
